Capricor Therapeutics (CAPR) Reports Q4 Loss of $0.21/Share
Capricor Therapeutics (NASDAQ: CAPR) reported Q4 EPS of ($0.21), versus ($0.21) reported last year.
For earnings history and earnings-related data on Capricor Therapeutics (CAPR) click here.